Related Experiment Video
Updated: Jun 26, 2025

07:51
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
17.3K
Immunometabolic adaptation in monocytes underpins functional changes during pregnancy
April Rees1, Benjamin J Jenkins1, Roberto Angelini1
1Institute of Life Science, Swansea University Medical School, Swansea SA2 8PP, Wales, UK.
Iscience
|May 13, 2024
Summary
Pregnancy alters monocyte metabolism, reducing mitochondrial function and shifting immune properties. This metabolic plasticity in monocytes could inform treatments for pregnancy complications and immune diseases.
Area of Science:
- Immunology
- Metabolic studies
- Pregnancy research
Background:
- Metabolic heterogeneity influences immune cell function.
- Physiological metabolic changes during pregnancy impact maternal and fetal fuel needs.
- These immune changes may affect pathogen responses and autoimmune disease activity.
Purpose of the Study:
- To investigate metabolic reprogramming in monocytes during pregnancy.
- To understand how these changes affect monocyte function and immune responses.
- To explore potential therapeutic targets for pregnancy-related conditions and immune diseases.
Main Methods:
- Analysis of peripheral blood monocytes from pregnant women at term.
- Assessment of mitochondrial mass, respiration, and cardiolipin content.
- Measurement of cytokine production in response to muramyl dipeptide (MDP) and lipopolysaccharide (LPS).
Main Results:
- Monocytes exhibited a shift from M2-like to M1-like properties.
- Reductions in mitochondrial mass, maximal respiration, and cardiolipin were observed.
- Cytokine production stimulated by MDP was decreased, while LPS-stimulated production remained unchanged.
- Glycolysis was not significantly affected.
Conclusions:
- Monocytes in late gestation show down-regulated, mitochondrially-centered metabolic capabilities.
- This demonstrates natural plasticity in monocyte phenotype and function during pregnancy.
- Findings may reveal targets for improving pregnancy outcomes and treating metabolic/immune diseases.

